Physician profile
Jon J Auger
NPI 1225071475
$1,332.77
in general payments reported to CMS, 2019-2025
15 companies · $287 in 2025
The $287 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $52.73 · 2020: $108 · 2021: $213 · 2022: $249 · 2023: $236 · 2024: $188 · 2025: $287.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $542 · Travel and Lodging: $168.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $542.00 |
| Travel and Lodging | $168.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $243.66 | 2023-2025 | Erleada |
| Procept Biorobotics Corporation | $186.74 | 2025 | |
| Baxter Healthcare | $168.29 | 2024 | Perclot |
| Teleflex LLC | $152.33 | 2022 | |
| Astellas Pharma US INC | $130.14 | 2019-2021 | |
| Boston Scientific Corporation | $92.46 | 2020 | |
| Rochester Medical Corporation | $92.26 | 2021-2022 | |
| Pfizer INC. | $63.07 | 2019-2021 | |
| Abbvie INC. | $61.09 | 2021-2022 | |
| Valencia Technologies Corporation | $36.92 | 2025 | Ecoin Device Kit |
| Coloplast Corp | $27.33 | 2019-2023 | Speedicath |
| Olympus America INC. | $19.95 | 2025 | Itind System |
| Vertex Pharmaceuticals Incorporated | $19.55 | 2025 | |
| Blue Earth Diagnostics | $19.55 | 2021 | |
| Bioprotect Medical, INC. | $19.43 | 2024 | Bioprotect Balloon Implant System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Auger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.